GlaxoSmithKline PLC, Carlsbad Technology Inc.

Overview and Scope
Herpes simplex virus treatment refers to a kind of treatment for infections caused by herpes simplex virus (HSV) or herpes, a common illness that can result in excruciating blisters or ulcers. This treatment is used to treat the symptoms caused by the virus infection through antiviral creams or tablets.

Sizing and Forecast
The herpes simplex virus treatment market size has grown strongly in recent years. It will grow from $2.24 billion in 2023 to $2.39 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%.  The  growth in the historic period can be attributed to increased prevalence of hsv infections, antiviral medications development, clinical research and drug approvals, patient education and awareness, global efforts for std prevention.

The herpes simplex virus treatment market size is expected to see strong growth in the next few years. It will grow to $3.1 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%.  The growth in the forecast period can be attributed to advancements in antiviral therapies, focus on preventive measures, potential vaccine development, telemedicine and remote consultations, global health initiatives. Major trends in the forecast period include incorporation of nanotechnology, telemedicine for remote consultations, natural and herbal therapies, strategies for neonatal herpes prevention, antiviral drug resistance monitoring.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/herpes-simplex-virus-treatment-global-market-report

The herpes simplex virus treatment market covered in this report is segmented –

1) By Type: Herpes Simplex Virus-1 Infection, Herpes Simplex Virus-2 Infection
2) By Drug Type: Acyclovir, Valacyclovir, Famciclovir, Other Drugs
3) By Route Of Administration: Oral, Injection, Topical
4) By Vaccine: Simplirix, Other Vaccines
5) By Distribution Channel: Hospital Pharmacies, Drug store, Retail Pharmacies, Online Providers

North America was the largest region in the herpes simplex virus treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global herpes simplex virus treatment market report during the forecast period. The regions covered in the herpes simplex virus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=10691&type=smp

Major Driver Impacting Market Growth
The surge in the prevalence of sexually transmitted infections is expected to propel the growth of the herpes simplex virus treatment market going forward. Sexually transmitted diseases (STDs) or sexually transmitted infections (STIs) refer to an illness brought on by an infection with specific bacteria, viruses, or other microorganisms that can be spread from one person to another through blood, semen, vaginal secretions, or other body fluids during sexual intercourse with an infected partner. Herpes simplex virus or HSV treatment is primarily used to treat sexually transmitted illnesses, including urethritis, cervicitis, and infections that cause genital ulcers. For instance, in April 2023, according to the Center for Disease Control and Prevention, a US-based national public health agency, the number of sexually transmitted diseases (STDs) in the USA increased between 2020 and 2021, reaching a total of more than 2.5 million. Further, syphilis cases in the US increased by 32% from 133,954 in 2020 to 176,713 in 2021. Therefore, the surge in the prevalence of sexually transmitted infections is driving the growth of the herpes simplex virus treatment market.

Key Industry Players
Major companies operating in the herpes simplex virus treatment market report are GlaxoSmithKline plc, Carlsbad Technology Inc., Glenmark Pharmaceuticals Ltd., Fresenius Kabi AG, Apotex Inc., Mylan N.V., Teva Pharmaceuticals Industries Ltd., Sanofi S.A., Novartis AG, Zydus Pharmaceuticals Inc., Abbott Laboratories, Amneal Pharmaceuticals Inc., Pfizer Inc., Viatris Inc., Agenus Inc., Merck KGaA, Chimerix Inc., Avet Pharmaceuticals Inc., EPI Health LLC, Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Johnson & Johnson, AbbVie Inc., AstraZeneca plc, Gilead Sciences Inc., Bayer AG, Eli Lilly and Company, BioCryst Pharmaceuticals Inc., AiCuris Anti-infective Cures GmbH, CureVac AG

The herpes simplex virus treatment  market report table of contents includes:

1. Executive Summary

2. Herpes Simplex Virus Treatment Characteristics

3. Herpes Simplex Virus Treatment Trends And Strategies

4. Herpes Simplex Virus Treatment – Macro Economic Scenario

5. Global Herpes Simplex Virus Treatment Size and Growth

…..

32. Global Herpes Simplex Virus Treatment Competitive Benchmarking

33. Global Herpes Simplex Virus Treatment Competitive Dashboard

34. Key Mergers And Acquisitions In The Herpes Simplex Virus Treatment

35. Herpes Simplex Virus Treatment Future Outlook and Potential Analysis

36. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model